Category

0
3
Culture-based screening strategy reduced incidence of immigration-related tuberculosis in U.S.
Implementation of the culture-based algorithm may have substantially reduced the incidence of tuberculosis (TB) among newly arrived, foreign-born persons in the United States, according to an...
medicalnewstoday.com
almost 6 years ago

0
6
Epidemiology of human mycobacterium bovis disease, california, USA, 2003-2011
Tuberculosis (TB) can be caused by more than one type of bacteria, one of which is Mycobacterium bovis. TB caused by M.
medicalnewstoday.com
almost 6 years ago

0
15
Characteristics of tuberculosis cases that started outbreaks in the United States, 2002-2011
A CDC analysis of the initial cases leading to 26 tuberculosis (TB) outbreaks in the U.S.
medicalnewstoday.com
almost 6 years ago

0
11
Antiangiogenesis drugs could make major improvement in tuberculosis treatment
Normalizing blood vessels within TB lung lesions may increase drug delivery, reduce development of resistanceUse of the same antiangiogenesis drugs that have improved...
medicalnewstoday.com
almost 6 years ago

0
8
Myriad RBN joins Institut Pasteur in the global fight against tuberculosis
Myriad RBM, a wholly owned subsidiary of Myriad Genetics, Inc. has announced that it will assist the Institut Pasteur in a public-private research collaboration to fight the global...
medicalnewstoday.com
almost 6 years ago

0
18
Anticonvulsants for cocaine dependence | Cochrane
Cocaine is an illicit drug available as a powder for intranasal or intravenous use or smoked as crack. Short- and long-term use of this drug results in the spread of infectious diseases (for example, AIDS, hepatitis, tuberculosis), crime, violence and prenatal drug exposure. Cocaine dependence is associated with medical and psychosocial complications and is a major public health problem. No proven pharmacological treatment for cocaine dependence is known. Antidepressant, anticonvulsant and dopaminergic medications have all been studied. The present review looked at the efficacy and safety of anticonvulsant drugs for treating cocaine dependence, both as a class and individually.
cochrane.org
almost 6 years ago

0
4
Limitations of current tuberculosis screening tests in immunosuppressed patients
We agree that a combination of an interferon γ release assay (IGRA; QuantiFERON-TB Gold in-Tube (QFT-IT) or TSPOT.TB) and a tuberculin skin test is the most sensitive approach to screening for latent tuberculosis infection in patients with rheumatological diseases before starting biological drugs.1
feeds.bmj.com
almost 6 years ago
0
3
Lucentis excluded from WHO list of essential medicines
The World Health Organization has rejected an application by Novartis to include ranibizumab (Lucentis) for neovascular eye diseases in the most recent update of its essential medicines list.1 The agency has, however, included “groundbreaking” new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia), and multidrug resistant tuberculosis, among others.
feeds.bmj.com
almost 6 years ago
0
3
Lucentis excluded from WHO list of essential medicines
The World Health Organization has rejected an application by Novartis to include ranibizumab (Lucentis) for neovascular eye diseases in the most recent update of its essential medicines list.1 The agency has, however, included “groundbreaking” new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia), and multidrug resistant tuberculosis, among others.
feeds.bmj.com
almost 6 years ago
0
6
Lucentis excluded from WHO list of essential medicines
The World Health Organization has rejected an application by Novartis to include ranibizumab (Lucentis) for neovascular eye diseases in the most recent update of its essential medicines list.1 The agency has, however, included “groundbreaking” new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia), and multidrug resistant tuberculosis, among others.
feeds.bmj.com
almost 6 years ago
0
3
Lucentis excluded from WHO list of essential medicines
The World Health Organization has rejected an application by Novartis to include ranibizumab (Lucentis) for neovascular eye diseases in the most recent update of its essential medicines list.1 The agency has, however, included “groundbreaking” new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia), and multidrug resistant tuberculosis, among others.
feeds.bmj.com
almost 6 years ago
0
6
Lucentis excluded from WHO list of essential medicines
The World Health Organization has rejected an application by Novartis to include ranibizumab (Lucentis) for neovascular eye diseases in the most recent update of its essential medicines list.1 The agency has, however, included “groundbreaking” new treatments for hepatitis C, a variety of cancers (including breast cancer and leukaemia), and multidrug resistant tuberculosis, among others.
feeds.bmj.com
almost 6 years ago